Qnovia has secured a worldwide exclusive licence to a new antimicrobial peptide developed at the University of Virginia, ...
Sanofi has received European Commission approval to extend the indication of MenQuadfi to infants from six weeks of age, broadening access to protection against invasive meningococcal disease caused ...
Polpharma Biologics has announced that the FDA and EMA have accepted for review the BLA and MAA for PB016, a proposed ...
CelLBxHealth has announced the publication of an independent, peer‑reviewed study demonstrating that its Parsortix platform ...
Johnson & Johnson has announced positive topline results from the phase 3 MonumenTAL‑6 study, which evaluated TECVAYLI and ...
Infinitopes has dosed the first patient with ITOP1, its lead investigational therapeutic cancer vaccine, marking the first ...
The CHMP has adopted a positive opinion recommending approval of Lynavoy for the treatment of cholestatic pruritus in adults ...
Atsena Therapeutics has received orphan designation from the European Medicines Agency for its two clinical‑stage gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results